This inventor holds 1 USPTO granted patent. Top assignee: Jb Therapeutics Inc.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Glenn L Cooper: Innovator in Non-Psychoactive Therapeutics
Introduction
Glenn L Cooper is a notable inventor based in Wayland, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of non-psychoactive derivatives of tetrahydrocannabinol. His work focuses on innovative treatments for interstitial cystitis, a painful bladder condition.
Latest Patents
Glenn L Cooper holds 1 patent related to his invention, which involves the use of (6aR,10aR)-Δ9-tetrahydrocannabinol-11-oic acids. This invention is aimed at providing therapeutic solutions for interstitial cystitis and includes methods for formulating and administering these compounds effectively.
Career Highlights
Throughout his career, Glenn has been dedicated to advancing medical treatments through innovative research. His work has the potential to improve the quality of life for individuals suffering from interstitial cystitis by offering non-psychoactive alternatives.
Collaborations
Glenn collaborates with Bobby W Sandage, Jr., contributing to the development of therapeutic agents in the pharmaceutical industry.
Conclusion
Glenn L Cooper's innovative work in the field of non-psychoactive therapeutics showcases his commitment to improving healthcare solutions. His contributions are paving the way for new treatments that can significantly benefit patients.